| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.29 | 0.05 |